Quintero Gilberto 4
4 · Organogenesis Holdings Inc. · Filed Feb 20, 2026
Research Summary
AI-generated summary of this filing
Organogenesis (ORGO) Director Gilberto Quintero Receives RSU Award
What Happened
- Gilberto Quintero, a director of Organogenesis Holdings Inc. (ORGO), received an award of 48,828 restricted stock units (RSUs) on February 18, 2026. The units were reported with an acquisition price of $0.00. Each RSU represents the contingent right to one share of Organogenesis Class A common stock and the RSUs vest in full on February 15, 2027.
- This is an equity award (transaction code A), not an open-market purchase or sale. Awards are common as compensation or incentive and do not represent an immediate cash outlay or sale.
Key Details
- Transaction date: 2026-02-18; Form 4 filed: 2026-02-20 (timely filing).
- Award: 48,828 RSUs; reported acquisition price: $0.00.
- Vesting: RSUs vest in full on February 15, 2027 (see footnote).
- Shares owned after transaction: not disclosed on the provided excerpt.
- Footnote: Each RSU converts to one share of Class A common stock upon vesting.
Context
- RSU grants are a compensation tool and do not necessarily indicate the insider is buying or selling stock; value to the insider is realized only if and when the RSUs vest and convert to shares (and then may be taxable).
- Because this is an award (not a sale), it’s generally less informative about the director’s near-term market view than open-market purchases or sales.
Insider Transaction Report
Form 4
Quintero Gilberto
Director
Transactions
- Award
Class A Common Stock
[F1]2026-02-18+48,828→ 239,073 total
Footnotes (1)
- [F1]Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2027.
Signature
/s/ William R. Kolb, Attorney-in-Fact|2026-02-20